Inotiv, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Inotiv, Inc. announced its emergence from Chapter 11 bankruptcy protection, having reduced its debt by approximately $326 million and strengthened its capital structure with new capital from existing stakeholders.
NASDAQ
Inotiv, Inc. has secured a $65.5 million debtor-in-possession credit facility to support operations during its Chapter 11 bankruptcy proceedings.
NASDAQ
Inotiv, Inc. has filed for Chapter 11 bankruptcy protection to implement a pre-packaged restructuring plan, aiming to reduce debt by approximately $326 million and emerge as a private company.
NASDAQ
Inotiv, Inc. has entered into a Second Supplemental Indenture to extend the grace period for interest payments on its 3.25% Convertible Senior Notes due 2027.
NASDAQ
Inotiv, Inc. announced a Ninth Amendment to its Credit Agreement, introducing a $40 million Bridge Facility to repay revolving loans and fund corporate needs, alongside other material agreements and board changes.
NASDAQ
Inotiv, Inc. reported a slight revenue increase in the first quarter of fiscal 2026, driven by strong growth in its Discovery and Safety Assessment segment, despite a decline in Research Models and Services.
NASDAQ
Inotiv, Inc. announced preliminary court approval for a derivative lawsuit settlement, including a $2.49 million insurance-funded payment and new corporate governance measures.
NASDAQ
Inotiv, Inc. received a notice from Nasdaq regarding non-compliance with the minimum bid price rule, initiating a 180-day period to regain compliance.
NASDAQ
Inotiv, Inc. announced improved financial results for the fourth quarter and full fiscal year 2025, driven by revenue growth and significantly reduced operating losses.
NASDAQ
Inotiv, Inc. announced preliminary unaudited financial results for the fourth quarter and full fiscal year 2025, showing revenue growth and strong contract awards in its DSA services business.
NASDAQ
Inotiv, Inc. announced settlements for securities class action and derivative lawsuits totaling $8.75 million, while facing new privacy class actions related to a recent cybersecurity incident and exploring debt refinancing.
NASDAQ
Inotiv, Inc. disclosed a cybersecurity incident on August 8, 2025, impacting certain systems and data, leading to business disruptions.
NASDAQ
Inotiv, Inc. announced significantly improved third-quarter fiscal 2025 financial results, with revenue up 23.5% and Adjusted EBITDA soaring, alongside the conclusion of a key SEC investigation.
NASDAQ
Inotiv, Inc. announced a 23.5% revenue increase and significant improvement in net loss and Adjusted EBITDA for the third quarter of fiscal 2025, alongside a positive resolution to its SEC investigation.
NASDAQ
Inotiv, Inc. announced that the U.S. Securities and Exchange Commission's Division of Enforcement has concluded its investigation into the company's non-human primate importation practices and does not intend to recommend an enforcement action.
NASDAQ
Inotiv, Inc. hosted its 2025 Investor Day, detailing strategic initiatives for margin expansion, organic growth, and operational efficiencies, alongside reporting Q2 2025 financial results including a 4.4% year-over-year revenue increase to $124.3 million.
NASDAQ
Inotiv's Q2 FY 2025 revenue increased by 4.4% to $124.3 million, while year-to-date revenue declined by 4.1% to $244.2 million as the company progresses with site optimization plans.
NASDAQ
Inotiv, Inc. shareholders approved an amendment to the 2024 Equity Incentive Plan, increasing the number of shares available for issuance by 2,250,000, and elected two Class I directors at the annual meeting held on March 13, 2025.
NASDAQ
Inotiv, Inc. settles a lawsuit with Freese and Nichols, Inc. (FNI) regarding a faulty lagoon design at its Alice, Texas location, resulting in a $7.55 million payment to Inotiv.
NASDAQ
Inotiv's first quarter fiscal 2025 revenue decreased by 11.5% to $119.9 million, with the company focusing on strengthening financial stability and enhancing client experience.
NASDAQ
Inotiv, Inc. has announced a public offering of 6,000,000 common shares at $4.25 per share, with an option for the underwriter to purchase an additional 900,000 shares.
NASDAQ
Inotiv's fiscal year 2024 saw a 14.3% revenue decrease and a net loss of $108.9 million, impacted by restructuring, legal settlements, and a decline in non-human primate sales.
NASDAQ
Inotiv, Inc. has amended its credit agreement and secured $22.6 million in financing through the issuance of senior secured second lien notes and warrants.
NASDAQ
Inotiv, Inc. has entered into an agreement with Jefferies LLC to sell up to $50 million of its common shares through an at-the-market offering.
NASDAQ
Inotiv's third quarter fiscal 2024 results show a 32.8% revenue decrease and a net loss, impacted by lower demand and pricing in the Research Models and Services segment, alongside costs related to legal settlements.
NASDAQ
Inotiv, Inc. has reached a resolution with the U.S. Department of Justice regarding a criminal investigation into its former canine breeding facility, agreeing to pay $22 million in fines and make significant improvements to its animal care practices.
NASDAQ
Inotiv's second quarter fiscal 2024 revenue declined by 21.5% year-over-year, with a significant drop in Research Models and Services revenue, and the company reached an agreement in principle with the U.S. Department of Justice.
NASDAQ
Inotiv, Inc. shareholders approved the 2024 Equity Incentive Plan and elected three Class III board members at their annual meeting on March 14, 2024.
NASDAQ
Inotiv, Inc. announced a 10.3% increase in revenue for the first quarter of fiscal year 2024, reaching $135.5 million, driven by growth in both its Research Models and Services (RMS) and Discovery and Safety Assessment (DSA) segments.